More than 300,000 women die annually from cervical cancer—most from low- and middle-income countries. Here in a modest neighborhood in Quezon, Philippines, women are self-collecting samples for regular cervical cancer screening. Hear all about it in this four minute journey to SUCCESS. Listen to our podcast, “Success in Quezon City” Listen to more Jhpiego podcasts!
Maternal, Newborn & Child Health
Time to Amplify Maternal Health Gains With…
AMPLI – PPHI Accelerating Measurable Progress and Leveraging Investments for Postpartum Hemorrhage Impact Did you know? Postpartum hemorrhage (PPH) is the leading cause of maternal death worldwide. AMPLI-PPHI will catalyze early adoption and scale-up of new and recently recommended drugs to prevent or treat PPH in high-burden countries as part of an integrated package of
Jhpiego Awarded Unitaid Project to Catalyze Adoption and Scale-Up of Drugs for Postpartum Hemorrhage
August 16, 2022 Baltimore, MD—Jhpiego, a global leader in maternal health care, has been chosen to lead a new $18.5 million project funded by Unitaid that will inform how countries can introduce and accelerate use of key drugs to prevent and treat life-threatening bleeding after birth. The Accelerating Measurable Progress and Leveraging Investments for Postpartum